Top

Journal of General Internal Medicine

Published in:

01-01-2016 | Letter to the Editor

Industry Collaboration and Primary Guest Authorship of High-Impact Clinical Trials

Authors: Nitin Roper, MD, Deborah Korenstein, MD

Published in: Journal of General Internal Medicine | Issue 1/2016

Excerpt

The Authors’ Reply— …

Wislar JS, Flanagin A, Fontanarosa PB, Deangelis CD. Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ. 2011;343:d6128. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3202014&tool=pmcentrez&rendertype=abstract. Accessed May 28, 2014.

Mowatt G, Shirran L, Grimshaw JM, et al. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002;287(21):2769–71. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12038907. Accessed May 27, 2014.

Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280(3):222–4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9676661. Accessed May 27, 2014.

Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008;299(15):1800–12. doi:10.1001/jama.299.15.1800.PubMedCrossRef

Title: Industry Collaboration and Primary Guest Authorship of High-Impact Clinical Trials
Authors: Nitin Roper, MD
Deborah Korenstein, MD
Publication date: 01-01-2016
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue 1/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-015-3402-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Collaboration and Authorship of High-Impact Randomized Clinical Trials

Horner’s, Heterochromia, and Harlequins

Equanimity, Ambiguity, and the Physician’s Task

Capsule Commentary on Jenssen et al., Using Digital Technology to Engage and Communicate with Patients: A Survey of Patient Attitudes

Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines

Unauthorized Immigrants Prolong the Life of Medicare’s Trust Fund

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials